Global Medical Patient Financing Market Overview:
Healthcare refers to any medical procedure that is intended to improve a person's well-being. The management of funds for these medical resources is referred to as medical patient financing. This type of financing, on a personal level, refers to payments for hospital care, physician care, dental care, prescriptions, and other personal medical services. When patients are unable to pay for medical expenses out of pocket, healthcare financing acts as credit and allows them to receive care. Medical patient financing is being fuelled by rising healthcare costs.
|Unit||Value (USD Million)|
|Customization Scope||Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility|
Growing Prevalence of Provider-Facilitated Patient Financing and Rise of Guest-Pay
Market Growth Drivers:
Rising Medical Expenditure in Developing Countries and Surge in Chronic Diseases and Advances in Early Diagnosis are Driving the Market
Lack of Awareness in Developing Economies
High Cost of Interest on Patient Financing Loans
Increasing Geriatric Population and Growing Adoption of Point Of Sale Patient Financing
The demand for Medical Patient Financing is increasing. Businesses in this sector face global competition from market leaders who control a large share of the market. Companies are differentiating their products from competition by employing environmentally friendly materials and manufacturing techniques. The Leading Players are engaging in strategic global expansion to maintain their Market Position. Players are expected to focus on the creation of new compounds, which would likely drive the worldwide market forward over the forecast period.
Some of the key players profiled in the report are Wells Fargo Health (United States), Siemens Healthineers (Germany), Kingsbridge Healthcare Finance (United States), CommerceHealthcare (United States), ClearBalance HealthCare (United States), Medicard (Canada), AccessOne (United States), Sunbit (United States), ClearGage (United States) and Prosper Healthcare Lending (United States). Additionally, following companies can also be profiled that are part of our coverage like PrimaHealth Credit (United States) and Curae (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Medical Patient Financing market by 2028.
In August 2021 CommerceHealthcare had announced the launch of new patient financing options through the integration of Health Services Financing (HSF). This interface allows patients to be enrolled in HSF more quickly. Healthcare providers can offer the HSF programme directly through their patients' MyChart accounts using the new HSF Patient Enrollment app accessible in the App Orchard. The patient registration method is entirely self-service.
What Can be Explored with the Medical Patient Financing Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Medical Patient Financing Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Medical Patient Financing
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Medical Patient Financing market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Medical Patient Financing market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture and Capitalist, New entrants/investors, Analysts and Strategic Business Partners, Healthcare Providers and End-use industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.